BRIVLERA
Google image searchProduct monograph
Active ingredient
brivaracetam, 10 MG/ML
DIN: 02452995
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: UCB CANADA INC
Date: 10-OCT-2018
ATC:
- N03 — ANTIEPILEPTICS (ATC, ATC/DDD, )
- N03A — ANTIEPILEPTICS (ATC, ATC/DDD)
- N03AX — Other antiepileptics (ATC, ATC/DDD)
- N03AX23 — BRIVARACETAM (ATC/DDD)
